These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 36542542)

  • 1. Off to a good start? Review of the predictivity of reactivity methods modelling the molecular initiating event of skin sensitization.
    Alépée N; Tourneix F; Singh A; Ade N; Grégoire S
    ALTEX; 2023; 40(4):606-618. PubMed ID: 37314401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a hierarchical support vector regression-based in silico model for the prediction of the cysteine depletion in DPRA.
    Ta GH; Weng CF; Leong MK
    Toxicology; 2024 Mar; 503():153739. PubMed ID: 38307191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the reactivity of nanoparticles to peptides through direct peptide reactivity assay (DPRA) using a high pressure liquid chromatography system with a diode array detector.
    Kim EN; Seo JA; Kim BH; Jeong GS
    Toxicol Res; 2023 Jul; 39(3):485-495. PubMed ID: 37398568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of skin sensitization using machine learning.
    Im JE; Lee JD; Kim HY; Kim HR; Seo DW; Kim KB
    Toxicol In Vitro; 2023 Dec; 93():105690. PubMed ID: 37660996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency classification of isothiazolinone compounds based on defined approaches of skin sensitization in OECD GL 497.
    Kim H; Park J; Lee H; Son J; Park Y; Bae H; Park SY; Lee SH; Seo J; Shin S; Park K
    Environ Anal Health Toxicol; 2023 Dec; 38(4):e2023026-0. PubMed ID: 38298045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GARD™skin and GARD™potency: A proof-of-concept study investigating applicability domain for agrochemical formulations.
    Corvaro M; Henriquez J; Settivari R; Mattson U; Forreryd A; Gradin R; Johansson H; Gehen S
    Regul Toxicol Pharmacol; 2024 Mar; 148():105595. PubMed ID: 38453128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a 96-Well Electrophilic Allergen Screening Assay for Skin Sensitization Using a Measurement Science Approach.
    Petersen EJ; Uhl R; Toman B; Elliott JT; Strickland J; Truax J; Gordon J
    Toxics; 2022 May; 10(5):. PubMed ID: 35622670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino Chemoassay Profiling of Aromatic Aldehydes-Unraveling Drivers of Their Skin Sensitization Potency.
    Böhme A; Ulrich N; Schüürmann G
    Chem Res Toxicol; 2023 Jul; 36(7):1055-1070. PubMed ID: 37315223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of peptide reactivity assays for skin sensitisation hazard identification and risk assessment.
    Gerberick GF
    Altern Lab Anim; 2016 Oct; 44(5):437-442. PubMed ID: 27805826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide reactivity assays for skin sensitisation - scope and limitations.
    Roberts DW
    Crit Rev Toxicol; 2022 Jul; 52(6):420-430. PubMed ID: 36542542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetic direct peptide reactivity assay (kDPRA): Intra- and inter-laboratory reproducibility in a seven-laboratory ring trial.
    Wareing B; Kolle SN; Birk B; Alépée N; Haupt T; Kathawala R; Kern PS; Nardelli L; Raabe H; Rucki M; Ryan CA; Verkaart S; Westerink WMA; Landsiedel R; Natsch A
    ALTEX; 2020; 37(4):639-651. PubMed ID: 32521036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical review of the kinetic direct peptide reactivity assay (kDPRA) for skin sensitizer potency assessment - taking it forward.
    Roberts DW
    Crit Rev Toxicol; 2021 Nov; 51(10):805-819. PubMed ID: 35166165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated skin sensitization assessment based on OECD methods (II): Hazard and potency by combining kinetic peptide reactivity and the "2 out of 3" Defined Approach.
    Natsch A; Gerberick GF
    ALTEX; 2022; 39(4):647-655. PubMed ID: 35404468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictivity of the kinetic direct peptide reactivity assay (kDPRA) for sensitizer potency assessment and GHS subclassification.
    Natsch A; Haupt T; Wareing B; Landsiedel R; Kolle SN
    ALTEX; 2020; 37(4):652-664. PubMed ID: 32840629
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.